Rapydan Topical Anaesthesia for Arterial Cannulation
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Arterial catheterization is painful and is associated with patient stress and anxiety.
Analgesia is usually provided by subcutaneous injection of local anesthetic. An alternative
is topical anaesthesia, such as Rapydan which is a novel topical anesthetic patch containing
70 mg each of lidocaine and tetracaine. We therefore tested the hypothesis that Rapydan patch
analgesia is non-inferior to subcutaneous local anesthetic.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Vienna
Collaborators:
Population Health Research Institute The Cleveland Clinic